MedPath

Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars

Not Applicable
Recruiting
Conditions
Scars
Insulin
Interventions
Other: Microneedling with topical application of saline
Other: Microneedling with topical application of regular insulin
Registration Number
NCT06021275
Lead Sponsor
Alexandria University
Brief Summary

Recently, few studies have attempted to test the regenerative effects of human insulin application by microneedling on atrophic scars versus other topical preparations. However, the scars were limited etiologically to acne scars. In addition, a lack of inclusion of a control group instead of comparing topical preparations with insulin was also a limitation to these studies. A control group consisting of microneedling alone would have served as a better comparison in order to determine whether the effects of microneedling are augmented by topical protein-rich preparations.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. Patients aged 12 to 60 years
  2. Atrophic scars (traumatic or surgical)
  3. Completely healed scars
Exclusion Criteria
  1. Patients with a tendency or history of hypertrophic or keloidal scars
  2. Patients who received treatment for their scar in the past 3 months
  3. Diabetic patients or those with a history of Dysglycemia
  4. Pregnant, or lactating females
  5. Patients with active infection at the site of scar
  6. Patients currently receiving isotretinoin treatment or in the past month

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Microneedling onlyMicroneedling with topical application of saline-
Microneedling with topical application of regular insulinMicroneedling with topical application of regular insulin-
Primary Outcome Measures
NameTimeMethod
Change in Scar4 months

According the different scar assessment scores (e.g.POSAS score - The Patient and Observer Scar Assessment Scale score, range from 6 to 60, the higher the score the worse the scar, lowering in the score denotes improvement )

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Alexandria University, Faculty of Medicine

🇪🇬

Alexandria, Egypt

© Copyright 2025. All Rights Reserved by MedPath